These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 231199)

  • 21. Inverse relationship between adenosine deaminase and purine nucleoside phosphorylase in rat lymphocyte populations.
    Barton R; Martiniuk F; Hirschhorn R; Goldschneider I
    Cell Immunol; 1980 Jan; 49(1):208-14. PubMed ID: 6766090
    [No Abstract]   [Full Text] [Related]  

  • 22. Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms.
    Mitchell BS; Kelley WN
    Ann Intern Med; 1980 Jun; 92(6):826-31. PubMed ID: 6247948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [RNA degradation enzymes and purine nucleosides in the lymphocytes of patients with multiple sclerosis].
    Procházková L; Rendeková V; Pechán I
    Cesk Neurol Neurochir; 1987 Nov; 50(6):380-5. PubMed ID: 3123077
    [No Abstract]   [Full Text] [Related]  

  • 24. Lymphoblast purine pathway enzymes in B-cell acute lymphoblastic leukemia.
    Reaman GH; Blatt J; Poplack DG
    Blood; 1981 Aug; 58(2):330-2. PubMed ID: 6264997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress in understanding the mechanism of immunodeficiency disease associated with defects in purine metabolism.
    Seegmiller JE
    Monogr Hum Genet; 1978; 10():88-91. PubMed ID: 102926
    [No Abstract]   [Full Text] [Related]  

  • 26. Age-dependency of adenosine deaminase and purine nucleoside phosphorylase activities in rat spleen and thymus.
    Peters GJ; Oosterhof A; Veerkamp JH
    Biol Neonate; 1982; 42(3-4):195-200. PubMed ID: 6814540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleotide metabolism in cultured T cells and in cells of patients deficient in adenosine deaminase and purine nucleoside phosphorylase.
    Cohen A; Gudas LJ; Ullman B; Martin DW
    Ciba Found Symp; 1978; (68):101-14. PubMed ID: 115659
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.
    Hirschhorn R; Ratech H
    Curr Top Hematol; 1983; 4():1-35. PubMed ID: 6413135
    [No Abstract]   [Full Text] [Related]  

  • 29. [Congenital immunodeficiency with adenosine deaminase and purine nucleoside phosphorylase deficiency].
    Sakura N; Usui T; Ito K
    Nihon Rinsho; 1977 Aug; 35(8):2564-80. PubMed ID: 411964
    [No Abstract]   [Full Text] [Related]  

  • 30. [Congenital immunodeficiency syndrome with adenosine deaminase and purine nucleoside phosphorylase deficiencies (1)].
    Sakura N; Usui T; Ito K
    Nihon Rinsho; 1977 Jul; 35(7):2397-403. PubMed ID: 411963
    [No Abstract]   [Full Text] [Related]  

  • 31. Expression of adenosine deaminase and purine nucleoside phosphorylase isozymes in lymphohemopoietic precursor cells and normal and neoplastic lymphoid populations.
    Barton RW
    Cell Immunol; 1982 Nov; 73(2):207-15. PubMed ID: 6819088
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunodeficiency secondary to adenosine deaminase deficiency and purine nucleoside phosphorylation deficiency.
    Carson DA; Carrera CJ
    Semin Hematol; 1990 Jul; 27(3):260-9. PubMed ID: 2115692
    [No Abstract]   [Full Text] [Related]  

  • 33. Activity of adenosine deaminase and of purine nucleoside phosphorylase in peripheral lymphocytes from patients with acquired immunological disorders.
    Sidi Y; Boer P; Pick I; Pinkhas J; Sperling O
    Biomedicine; 1980 Apr; 33(2):39-41. PubMed ID: 6773594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3848-52. PubMed ID: 6808516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inherited immunodeficiency diseases: relationship to lymphocyte metabolic dysfunction.
    Giblett ER; Polmar SH
    Prog Med Genet; 1979; 3():177-219. PubMed ID: 118484
    [No Abstract]   [Full Text] [Related]  

  • 36. Purine enzyme levels in rheumatoid arthritis.
    Appelboom T; Mandelbaum I; Vertongen F
    J Rheumatol; 1985 Dec; 12(6):1075-8. PubMed ID: 3005561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: overview, genetic heterogeneity and therapy.
    Hirschhorn R
    Birth Defects Orig Artic Ser; 1983; 19(3):73-81. PubMed ID: 6418227
    [No Abstract]   [Full Text] [Related]  

  • 38. Enzyme defects in purine metabolism and immunodeficiencies.
    Ito K
    Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1764-71. PubMed ID: 3939170
    [No Abstract]   [Full Text] [Related]  

  • 39. Adenosine deaminase and purine nucleoside phosphorylase deficiency: how they were discovered and what they may mean.
    Giblett ER
    Ciba Found Symp; 1978; (68):3-18. PubMed ID: 115664
    [No Abstract]   [Full Text] [Related]  

  • 40. Purine degradative enzymes in circulating malignant cells of patients with chronic B cell neoplasia.
    Ho AD; Knauf W; Ganeshaguru K; Hunstein W; Hoffbrand AV
    Hematol Oncol; 1987; 5(1):9-17. PubMed ID: 3032762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.